Trilogy Capital’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,189
Closed -$221K 376
2025
Q2
$221K Sell
2,189
-126
-5% -$11.8K 0.01% 348
2025
Q1
$214K Sell
2,315
-361
-13% -$35.2K 0.01% 323
2024
Q4
$259K Sell
2,676
-1,427
-35% -$140K 0.01% 294
2024
Q3
$390K Sell
4,103
-273
-6% -$25.1K 0.02% 252
2024
Q2
$395K Sell
4,376
-1,327
-23% -$117K 0.02% 234
2024
Q1
$510K Sell
5,703
-2,477
-30% -$209K 0.03% 197
2023
Q4
$667K Sell
8,180
-1,292
-14% -$97.8K 0.04% 168
2023
Q3
$694K Sell
9,472
-345
-4% -$26.2K 0.05% 151
2023
Q2
$758K Sell
9,817
-865
-8% -$61.9K 0.05% 156
2023
Q1
$757K Sell
10,682
-4,161
-28% -$294K 0.05% 137
2022
Q4
$1.01M Buy
+14,843
New +$1.01M 0.07% 127

Other funds holding AVUS

Trilogy Capital's AVUS Position: Q3 2025 in Review

Trilogy Capital sold out of Avantis US Equity ETF (AVUS) in Q3 2025, closing a stake of 2,189 shares — an estimated $221K sold.

Trilogy Capital first reported a position in AVUS in Q4 2022 and held it in 11 quarters. The position peaked at $1.01M in Q4 2022. 483 funds tracked by Wall St. Rank hold AVUS as of Q3 2025.

  • Trilogy Capital reported no remaining Avantis US Equity ETF position as of Q3 2025 after selling out during the quarter.
  • Trilogy Capital sold 2,189 Avantis US Equity ETF shares in Q3 2025, an estimated $221K.
  • Trilogy Capital first reported a position in Avantis US Equity ETF in Q4 2022 and held it in 11 quarters.
  • Trilogy Capital's Avantis US Equity ETF position peaked at $1.01M in Q4 2022.
  • 483 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q3 2025.

Based on Trilogy Capital's 13F filing for Q3 2025, filed 24 Oct 2025.